OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies
Andrew H. Miller, Charles L. Raison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 68-75
Closed Access | Times Cited: 45
Andrew H. Miller, Charles L. Raison
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 68-75
Closed Access | Times Cited: 45
Showing 26-50 of 45 citing articles:
A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression
Seth C. Hopkins, Sasagu Tomioka, Steven T. Szabo, et al.
Contemporary Clinical Trials (2024) Vol. 145, pp. 107644-107644
Closed Access | Times Cited: 1
Seth C. Hopkins, Sasagu Tomioka, Steven T. Szabo, et al.
Contemporary Clinical Trials (2024) Vol. 145, pp. 107644-107644
Closed Access | Times Cited: 1
Dissecting depression symptoms: Multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulation
Jonas Hagenberg, Tanja Brückl, Mira Erhart, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 353-369
Open Access | Times Cited: 1
Jonas Hagenberg, Tanja Brückl, Mira Erhart, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 353-369
Open Access | Times Cited: 1
Depression with immuno-metabolic dysregulation: Testing pragmatic criteria to stratify patients
J.C. Zwiep, Y. Milaneschi, Erik J. Giltay, et al.
Brain Behavior and Immunity (2024) Vol. 124, pp. 115-122
Open Access | Times Cited: 1
J.C. Zwiep, Y. Milaneschi, Erik J. Giltay, et al.
Brain Behavior and Immunity (2024) Vol. 124, pp. 115-122
Open Access | Times Cited: 1
Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure
Andrew H. Miller, Charles L. Raison
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3167-3168
Closed Access | Times Cited: 3
Andrew H. Miller, Charles L. Raison
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3167-3168
Closed Access | Times Cited: 3
Chronic inflammation is associated with worsening working memory performance: Preliminary evidence from a diverse, longitudinal cohort of adolescents and young adults
Naoise Mac Giollabhui, Marin Kautz, Daniel P. Moriarity, et al.
Psychoneuroendocrinology (2024) Vol. 164, pp. 106992-106992
Closed Access
Naoise Mac Giollabhui, Marin Kautz, Daniel P. Moriarity, et al.
Psychoneuroendocrinology (2024) Vol. 164, pp. 106992-106992
Closed Access
In the afterglow: Immune dysfunction in schizophrenia spectrum disorders
Shiral S. Gangadin
(2024)
Open Access
Shiral S. Gangadin
(2024)
Open Access
Estimating heterogeneity of treatment effect in psychiatric clinical trials
Joshua S. Siegel, Jinglin Zhong, Sasagu Tomioka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Joshua S. Siegel, Jinglin Zhong, Sasagu Tomioka, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Living systematic review and meta-analysis of plasma-concentrations of antipsychotic drugs in carriers and non-carriers of variant CYP450 genotypes: Living systematic review protocol
F. Milosavljević, Stefan Leucht
F1000Research (2024) Vol. 13, pp. 452-452
Open Access
F. Milosavljević, Stefan Leucht
F1000Research (2024) Vol. 13, pp. 452-452
Open Access
Living systematic review and meta-analysis of plasma-concentrations of antipsychotic drugs in carriers and non-carriers of variant CYP450 genotypes: Living systematic review protocol
F. Milosavljević, Stefan Leucht
F1000Research (2024) Vol. 13, pp. 452-452
Open Access
F. Milosavljević, Stefan Leucht
F1000Research (2024) Vol. 13, pp. 452-452
Open Access
Precision Psychiatry Approach to Treat Depression and Anxiety Targeting the Stress Hormone System – V1b-antagonists as a Case in Point
Florian Holsboer, Marcus Ising
Pharmacopsychiatry (2024) Vol. 57, Iss. 06, pp. 263-274
Closed Access
Florian Holsboer, Marcus Ising
Pharmacopsychiatry (2024) Vol. 57, Iss. 06, pp. 263-274
Closed Access
Immuno-psychiatry: Dreams or reality?
Marion Leboyer, Ryad Tamouza
European Neuropsychopharmacology (2024) Vol. 89, pp. 10-11
Closed Access
Marion Leboyer, Ryad Tamouza
European Neuropsychopharmacology (2024) Vol. 89, pp. 10-11
Closed Access
How pharmacology can aid in the diagnosis of mental disorders
Roland Seifert, Bastian Schirmer, Johanna Seifert
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
Roland Seifert, Bastian Schirmer, Johanna Seifert
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access
What can the psychoneuroimmunology of yoga teach us about depression’s psychopathology?
Carola Chiarpenello, Katja Brodmann
Brain Behavior & Immunity - Health (2024) Vol. 42, pp. 100877-100877
Open Access
Carola Chiarpenello, Katja Brodmann
Brain Behavior & Immunity - Health (2024) Vol. 42, pp. 100877-100877
Open Access
Cognitive maps and schizophrenia
Matthew M. Nour, Yunzhe Liu, Mohamady El-Gaby, et al.
Trends in Cognitive Sciences (2024)
Open Access
Matthew M. Nour, Yunzhe Liu, Mohamady El-Gaby, et al.
Trends in Cognitive Sciences (2024)
Open Access
Interventional Psychiatry in India: Bridging Treatment Gaps and Expanding Horizons in Mental Health
Jithin Thekkelkuthiyathottil Joseph, Samir Kumar Praharaj
Indian Journal of Psychological Medicine (2024)
Open Access
Jithin Thekkelkuthiyathottil Joseph, Samir Kumar Praharaj
Indian Journal of Psychological Medicine (2024)
Open Access
The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. “Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies”
Gregory Jones, Rodrigo Machado‐Vieira
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3164-3166
Closed Access | Times Cited: 1
Gregory Jones, Rodrigo Machado‐Vieira
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3164-3166
Closed Access | Times Cited: 1
Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry
Elizabeth E. Klettke, Miles D. Holmes, Thomas D. Meyer, et al.
Personalized Medicine in Psychiatry (2023) Vol. 41-42, pp. 100112-100112
Closed Access | Times Cited: 1
Elizabeth E. Klettke, Miles D. Holmes, Thomas D. Meyer, et al.
Personalized Medicine in Psychiatry (2023) Vol. 41-42, pp. 100112-100112
Closed Access | Times Cited: 1
Metabolomics signatures of depression: the role of symptom profiles
Yuri Milaneschi, Hilde de Kluiver, Rick Jansen, et al.
Research Square (Research Square) (2023)
Open Access
Yuri Milaneschi, Hilde de Kluiver, Rick Jansen, et al.
Research Square (Research Square) (2023)
Open Access
